Invesco NASDAQ Biotech UCITS ETF Acc
- ISIN
- IE00BQ70R696
- Provider
- Invesco Investment Management Ltd
- Close Price
- $67.92 *
- Lipper Rating
- ESG Score
- Characteristics
- ETF
* Data as of 29 July 2026
Performance
Loading...
| Total | p.a. | |
|---|---|---|
| YTD | +14.37% | — |
| 1 Year | +45.56% | +45.56% |
| 3 Years | +59.51% | +16.81% |
| 5 Years | +29.23% | +5.26% |
| 10 Years | +121.05% | +8.25% |
Past performance is not a reliable indicator of future results. The value of an investment and the income from it can fall as well as rise.
Key Facts
| Asset Class | Equity |
| Holdings Classification | Equity United States Multi-Cap Growth |
| Geographical Focus | United States of America |
| Fund Size | $464,977,027 |
| Total Expense Ratio | 0.40% |
| Currency | USD |
| Domicile | IE |
| Managementstyle | Passive |
| SFDR Article | Article 6 |
Available in
Liechtenstein Life InvestLiechtenstein Life PensionLiechtenstein Life WealthProsperity Plus DEVWL-Förderkonzept für Bundeswehrangehörigebest value rentvalue invest VWLvalue rent business UK
Country Exposure
United States
87.6%
Netherlands
2.4%
United Kingdom
2.3%
Ireland
1.8%
Denmark
1.3%
Other
4.5%
Description
The investment objective of the fund is to achieve the total return performance of the NASDAQ Biotechnology Index, less fees, expenses and transaction costs. To achieve the objective the fund will use unfunded swaps. These Swaps are an agreement between the fund and an approved counterparty to excha...